Serum Concentrations of Cartilage Intermediate Layer Protein 2 Were Higher in Overweight and Obese Subjects

Abstract

Background. Cartilage intermediate layer protein 2 (CILP2) is associated with a variety of plasma lipoproteins and lipid traits. However, the correlation between CILP2 and obesity remains unknown. The aim of this study was to investigate the relationship between circulating CILP2 levels and obesity based on body mass index (BMI). Methods. A total of 252 subjects were divided into three groups: normal weight ( n = 124 ), overweight ( n = 94 ), and obese ( n = 34 ). Metabolic parameters were measured in a fasting state. Serum CILP2 concentration was tested by enzyme-linked immunosorbent assay. Multivariate linear regression analysis was used to explore the relationship between CILP2 and obesity. We also conducted bioinformatics analysis to further explore the genes and signaling pathways related to CILP2. Results. The concentrations of serum CILP2 in the overweight and obese groups were significantly higher than that in the normal weight group. In multiple linear regression analysis, BMI was positively correlated with CILP2 concentration after controlling gender and age. Being overweight and obese were independently correlated with CILP2 concentration after adjusting for gender, age, SBP, DBP, FBG, 2-hour OGTT blood glucose (2h-BG), fasting blood insulin (FIns), TG, TC, HDL-C, LDL-C, and FFA. Bioinformatics analysis showed that the genes related to CILP2 are primarily associated with lipid metabolism and insulin resistance. Conclusion. We speculate that CILP2 may attribute to metabolic disorders in obesity.

CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer

“…The CILP2 gene is associated with lipid and cardiovascular diseases in the Asian Malay population [ 19 ]. Furthermore, Li et al (2022), reported for the first time that CILP2 expression in the serum of obese individuals was higher than that in normal individuals [ 20 ]. In conclusion, many current studies suggest an association between CILP2 and lipid metabolism in cardiovascular disease.…”